Published in Clin Microbiol Infect on November 01, 2004
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2006) 4.17
Multidrug resistance in bacteria. Annu Rev Biochem (2009) 3.96
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 2.95
Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics (2009) 2.17
Quorum-quenching microbial infections: mechanisms and implications. Philos Trans R Soc Lond B Biol Sci (2007) 1.85
Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Chem Biol (2011) 1.82
Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin. Appl Environ Microbiol (2006) 1.54
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. Antimicrob Agents Chemother (2011) 1.32
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother (2010) 1.31
Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother (2010) 1.30
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis (2006) 1.29
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother (2011) 1.26
Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet (2012) 1.20
Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob Agents Chemother (2009) 1.19
Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection. Eur J Clin Pharmacol (2013) 1.17
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds. Antimicrob Agents Chemother (2006) 1.07
Drug discovery from natural products. J Ind Microbiol Biotechnol (2006) 1.07
Multicomponent drug efflux complexes: architecture and mechanism of assembly. Future Microbiol (2009) 1.02
Renal disposition of colistin in the isolated perfused rat kidney. Antimicrob Agents Chemother (2009) 1.02
In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J Antimicrob Chemother (2011) 0.99
Nitric oxide mediated Staphylococcus aureus pathogenesis and protective role of nanoconjugated vancomycin. Asian Pac J Trop Biomed (2011) 0.98
High yield expression of an AHL-lactonase from Bacillus sp. B546 in Pichia pastoris and its application to reduce Aeromonas hydrophila mortality in aquaculture. Microb Cell Fact (2010) 0.97
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class. Antimicrob Agents Chemother (2006) 0.97
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int (2013) 0.97
An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis (2005) 0.93
Bacillus anthracis thioredoxin systems, characterization and role as electron donors for ribonucleotide reductase. J Biol Chem (2012) 0.92
Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the bla NDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol (2015) 0.91
In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital. Eur J Clin Microbiol Infect Dis (2008) 0.90
Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature. J Med Chem (2010) 0.89
Biochemical characters and antibiotic susceptibility of Staphylococcus aureus isolates. Asian Pac J Trop Biomed (2011) 0.86
Diffusible signal factor (DSF) quorum sensing signal and structurally related molecules enhance the antimicrobial efficacy of antibiotics against some bacterial pathogens. BMC Microbiol (2014) 0.85
In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents. PLoS One (2016) 0.80
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect Dis (2016) 0.80
Structural and Functional Characterization of the LPS Transporter LptDE from Gram-Negative Pathogens. Structure (2016) 0.80
Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling. J Comput Aided Mol Des (2011) 0.80
Staphylococcus aureus Infection Induced Oxidative Imbalance in Neutrophils: Possible Protective Role of Nanoconjugated Vancomycin. ISRN Pharmacol (2012) 0.79
Biological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals. Int J Nanomedicine (2014) 0.78
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus. ACS Med Chem Lett (2015) 0.75
Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study. BMC Infect Dis (2014) 0.75
Production of valuable compounds by molds and yeasts. J Antibiot (Tokyo) (2016) 0.75
An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country. Indian J Med Res (2016) 0.75
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design. Front Neurosci (2017) 0.75
Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Org Biomol Chem (2014) 0.75
Application of 3D NMR for Structure Determination of Peptide Natural Products. J Org Chem (2015) 0.75
In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa. Sci Rep (2015) 0.75
High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma. Ther Drug Monit (2012) 0.75
Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria. Sci Rep (2016) 0.75
Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli. J Pharm (Cairo) (2013) 0.75
Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole. Adv Biomed Res (2016) 0.75
Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics. Antibiotics (Basel) (2017) 0.75